These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 30383083)

  • 1. Neurodegeneration With Brain Iron Accumulation: A Novel Mutation in the Ceruloplasmin Gene.
    Stelten BML; van Ommen W; Keizer K
    JAMA Neurol; 2019 Feb; 76(2):229-230. PubMed ID: 30383083
    [No Abstract]   [Full Text] [Related]  

  • 2. Neurodegeneration with brain iron accumulation.
    McNeill A; Chinnery PF
    Handb Clin Neurol; 2011; 100():161-72. PubMed ID: 21496576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aceruloplasminemia: Unique Clinical and MRI Findings in a Patient with a Novel Frameshift Mutation.
    Colucci F; Barca S; Cilia R; De Franco V; Elia AE; Golfrè Andreasi N; Romito L; Telese R; Braccia A; Leta V; Grisoli M; Panteghini C; Garavaglia B; Devigili G; Eleopra R
    Mov Disord Clin Pract; 2024 Aug; 11 Suppl 2(Suppl 2):S14-S16. PubMed ID: 38400595
    [No Abstract]   [Full Text] [Related]  

  • 4. A diagnostic approach for neurodegeneration with brain iron accumulation: clinical features, genetics and brain imaging.
    Salomão RP; Pedroso JL; Gama MT; Dutra LA; Maciel RH; Godeiro-Junior C; Chien HF; Teive HA; Cardoso F; Barsottini OG
    Arq Neuropsiquiatr; 2016 Jul; 74(7):587-96. PubMed ID: 27487380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aceruloplasminemia and putaminal cavitation.
    Riboldi GM; Anstett K; Jain R; Lau H; Swope D
    Parkinsonism Relat Disord; 2018 Jun; 51():121-123. PubMed ID: 29534945
    [No Abstract]   [Full Text] [Related]  

  • 6. Basal ganglia calcification in a case of PKAN.
    Fasano A; Shahidi G; Lang AE; Rohani M
    Parkinsonism Relat Disord; 2017 Mar; 36():98-99. PubMed ID: 28024710
    [No Abstract]   [Full Text] [Related]  

  • 7. Neurodegeneration with Brain Iron Accumulation: Genetic Diversity and Pathophysiological Mechanisms.
    Meyer E; Kurian MA; Hayflick SJ
    Annu Rev Genomics Hum Genet; 2015; 16():257-79. PubMed ID: 25973518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel ceruloplasmin mutation causing aceruloplasminemia with hepatic iron overload and diabetes without neurological symptoms.
    Rusticeanu M; Zimmer V; Schleithoff L; Wonney K; Viera J; Zimmer A; Hübschen U; Bohle RM; Grünhage F; Lammert F
    Clin Genet; 2014 Mar; 85(3):300-1. PubMed ID: 23557349
    [No Abstract]   [Full Text] [Related]  

  • 9. Brain and liver iron accumulation in aceruloplasminemia.
    Fujita K; Osaki Y; Harada M; Kono S; Miyajima H; Izumi Y; Kaji R
    Neurology; 2013 Dec; 81(24):2145-6. PubMed ID: 24323439
    [No Abstract]   [Full Text] [Related]  

  • 10. [GENETICALLY DETERMINED DISEASES ASSOCIATED WITH PATHOLOGICAL BRAIN IRON ACCUMULATION AND NEURODEGENERATION].
    Ács P; Molnár MJ; Klivényi P; Kálmán B
    Ideggyogy Sz; 2016 Mar; 69(5-6):157-66. PubMed ID: 27468605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aceruloplasminemia With Positive Ceruloplasm Gene Mutation.
    Kang HG; Kim M; Lee SC
    JAMA Ophthalmol; 2016 Jul; 134(7):e160816. PubMed ID: 27416276
    [No Abstract]   [Full Text] [Related]  

  • 12. Effectiveness of oral iron chelator treatment with deferasirox in an aceruloplasminemia patient with a novel ceruloplasmin gene mutation.
    Suzuki Y; Yoshida K; Aburakawa Y; Kuroda K; Kimura T; Terada T; Kono S; Miyajima H; Yahara O
    Intern Med; 2013; 52(13):1527-30. PubMed ID: 23812204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aceruloplasminemia in a Turkish adolescent with a novel mutation of ceruloplasmin gene: the first diagnosed case from Turkey.
    Meral Gunes A; Sezgin Evim M; Baytan B; Iwata A; Hida A; Avci R
    J Pediatr Hematol Oncol; 2014 Oct; 36(7):e423-5. PubMed ID: 25247888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case 193: Neuroferritinopathy--a brain iron accumulation and neurodegenerative disorder.
    Fatima Z; Ishigame K; Araki T
    Radiology; 2013 May; 267(2):650-5. PubMed ID: 23610097
    [No Abstract]   [Full Text] [Related]  

  • 15. Does aceruloplasminemia modulate iron phenotype in thalassemia intermedia?
    Pelucchi S; Pelloni I; Arosio C; Mariani R; Piperno A
    Blood Cells Mol Dis; 2016 Mar; 57():112-4. PubMed ID: 26777753
    [No Abstract]   [Full Text] [Related]  

  • 16. Idiopathic NBIA--clinical spectrum and transcranial sonography findings.
    Brüggemann N; Wuerfel J; Petersen D; Klein C; Hagenah J; Schneider SA
    Eur J Neurol; 2011 Jun; 18(6):e58-9. PubMed ID: 21244580
    [No Abstract]   [Full Text] [Related]  

  • 17. A homozygous splice variant in AP4S1 mimicking neurodegeneration with brain iron accumulation.
    Vill K; Müller-Felber W; Alhaddad B; Strom TM; Teusch V; Weigand H; Blaschek A; Meitinger T; Haack TB
    Mov Disord; 2017 May; 32(5):797-799. PubMed ID: 28150420
    [No Abstract]   [Full Text] [Related]  

  • 18. Oculogyric crises in PLA2G6 associated neurodegeneration.
    Rohani M; Shahidi G; Vali F; Lang AE; Slow E; Gahl WA; Behnam B
    Parkinsonism Relat Disord; 2018 Jul; 52():111-112. PubMed ID: 29574084
    [No Abstract]   [Full Text] [Related]  

  • 19. T2* and FSE MRI distinguishes four subtypes of neurodegeneration with brain iron accumulation.
    McNeill A; Birchall D; Hayflick SJ; Gregory A; Schenk JF; Zimmerman EA; Shang H; Miyajima H; Chinnery PF
    Neurology; 2008 Apr; 70(18):1614-9. PubMed ID: 18443312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extending the aceruloplasminemia phenotype: NBIA on imaging and acanthocytosis, yet only minor neurological findings.
    Kassubek R; Uttner I; Schönfeldt-Lecuona C; Kassubek J; Connemann BJ
    J Neurol Sci; 2017 May; 376():151-152. PubMed ID: 28431603
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.